Pay in 4 interest-free payments of $7.39 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
With some employers not covering weight loss drugs, members are using direct to consumer (DTC) telehealth solutions to get brand and compounded drugs
Escin Ia ameliorates DSS-induced chronic colitis in mice by inhibiting inflammation and oxidative stress via the LOXL2/MMP-9 pathway
The naltrexone/bupropion combination is marketed under the brand name Contrave and is FDA-approved specifically for weight loss in individuals with a: body mass index (BMI) of 30+ (obesity) BMI of 27+ (overweight) with at least one weight-related health condition, such as high blood pressure or type 2 diabetes
It also works well in those who dont have diabetes, but insurance is less likely to cover it or, if they do, the patients pay a portion, too. More than half of those who used it said they had difficulty paying for it, whether they had insurance or not
